Shay Capital’s Applied Therapeutics APLT Stock Holding History

Shay Capital’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-43,277	Closed	-$368K	–	313
2024 Q3	$368K	Buy	+43,277	New	+$255K	0.05%	199

Other funds holding APLT

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Shay Capital's APLT Position: Q4 2024 in Review

Shay Capital sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 43,277 shares — an estimated $368K sold.

Shay Capital first reported a position in APLT in Q3 2024 and held it in 1 quarter. The position peaked at $368K in Q3 2024. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

Shay Capital reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
Shay Capital sold 43,277 Applied Therapeutics shares in Q4 2024, an estimated $368K.
Shay Capital first reported a position in Applied Therapeutics in Q3 2024 and held it in 1 quarter.
Shay Capital's Applied Therapeutics position peaked at $368K in Q3 2024.
119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Shay Capital's 13F filing for Q4 2024, filed 14 Feb 2025.